BioCentury
ARTICLE | Clinical News

NuMA test of nuclear matrix protein in blood data

March 2, 1998 8:00 AM UTC

NMPS announced that data on 85 patients from its 501(k) submission of its NuMA test kit show better sensitivity for detecting colon cancer as compared to carcino-embryonic antigen (CEA) testing. A blinded analysis of banked specimens showed sensitivities of 47 for NuMA and 20 percent for CEA testing in Dukes B patients. Sensitivities were 48 and 38 percent respectively for Dukes C stage patients. ...